These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23018161)

  • 21. Re: Axel Heidenreich, Gunnar Aus, Michel Bolla, et al. EAU guidelines on prostate cancer. Eur Urol 2008;53:68-80.
    Kirollos M
    Eur Urol; 2008 Sep; 54(3):693-5; author reply 695-7. PubMed ID: 18367315
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy?
    Kishan AU; Hall WA; Spratt DE
    Eur Urol; 2019 May; 75(5):e133-e134. PubMed ID: 30670312
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Alberto Martini, Giorgio Gandaglia, R. Jeffrey Karnes, et al. Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer. Eur Urol Oncol 2019;2:456-63.
    Giannarini G; Crestani A; Ficarra V
    Eur Urol Oncol; 2019 Jul; 2(4):472-473. PubMed ID: 31277786
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Daher C. Chade, Shahrokh F. Shariat, Angel M. Cronin, et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur urol 2011;60:205-10.
    Qin X; Ye D
    Eur Urol; 2011 Oct; 60(4):e34. PubMed ID: 21764210
    [No Abstract]   [Full Text] [Related]  

  • 25. Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
    Lestingi JFP; Trinh QD; Coelho RF; Pontes J; Bastos DA; Nahas WC
    Eur Urol; 2021 Jun; 79(6):e184-e185. PubMed ID: 33685836
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Andrew Vickers, Caroline Bennette, Gunnar Steineck, et al. Individualized estimation of the benefit of radical prostatectomy from the scandinavian prostate cancer group randomized trial. Eur Urol 2012;62:204-9.
    Froehner M; P Wirth M
    Eur Urol; 2012 Sep; 62(3):e53; author reply e54. PubMed ID: 22727175
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to Francesco Montorsi, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol 2021;80:567-72.
    Vickers AJ
    Eur Urol; 2021 Dec; 80(6):e149. PubMed ID: 34600778
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur urol 2014;65:546-51.
    De Bari B; Arcangeli S; Alongi F
    Eur Urol; 2015 Feb; 67(2):e26. PubMed ID: 25281388
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7. Re: Ronald C. Chen. Postprostatectomy Radiotherapy: Whether and How Long to Give Concurrent Androgen Deprivation Therapy. Eur Urol 2016;69:58-9: Which patients need treatment intensification?
    Dal Pra A; Spahn M
    Eur Urol; 2016 Apr; 69(4):e74-e75. PubMed ID: 26508311
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to Zeynep G. Gul, Alberto Martini, and Carl A. Olsson's Letter to the Editor re: Jacob A. Burns, Adam B. Weiner, William J. Catalona, et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol 2019;75:846-52.
    Burns JA; Weiner AB; Kundu S
    Eur Urol; 2019 Oct; 76(4):e99-e100. PubMed ID: 31151679
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era: A. S. Kibel, J. P. Ciezki, E. A. Klein, C. A. Reddy, J. D. Lubahn, J. Haslag-minoff, J. O. Deasy, J. M. Michalski, D. Kallogjeri, J. F. Piccirillo, D. M. Rabah, C. Yu, M. W. Kattan And A. J. Stephenson; J Urol 2012; 187: 1259-1265.
    Stenmark MH; Hamstra DA
    J Urol; 2012 Dec; 188(6):2438-9; author reply 2439-40. PubMed ID: 23088984
    [No Abstract]   [Full Text] [Related]  

  • 32. Reply to Berardino De Bari, Stefano Arcangeli, and Filippo Alongi's letter to the editor re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur Urol 2014;65:546-51.
    Suardi N; Cozzarini C; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):e27-8. PubMed ID: 25281387
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy. Eur Urol 2016;70:588-96: Testing the Utility of Genomic Scores in the Setting of Recurrent Prostate Cancer After Radical Prostatectomy: We Can Certainly Do Better.
    Fossati N; Gandaglia G; Bossi A; Montorsi F; Briganti A
    Eur Urol; 2016 Oct; 70(4):e108-e109. PubMed ID: 26992282
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7.
    Hu YW
    Eur Urol; 2016 Dec; 70(6):e158. PubMed ID: 27166669
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5.
    Froehner M; Thomas C
    Eur Urol; 2019 Sep; 76(3):e75. PubMed ID: 31130432
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30: Radical Prostatectomy Versus Radiation for Clinically Localized Prostate Cancer: Two Systematic Reviews and a Randomized Controlled Trial.
    Lazar AA; Lizarraga TLC; Roach M
    Eur Urol; 2016 Jul; 70(1):e13-e14. PubMed ID: 26935558
    [No Abstract]   [Full Text] [Related]  

  • 37. Reply from Authors re: Giorgio Gandaglia, Alberto Briganti, Andrea Salonia, Francesco Montorsi. Excellent Erectile Function Recovery after Focal Therapy: Is This Enough? Eur Urol 2016;69:852-3: Focal Therapy Preserves Erectile Function in Men with Prostate Cancer.
    Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
    Eur Urol; 2016 May; 69(5):853-4. PubMed ID: 26695002
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Maria J. Ribal, Philip Cornford, Alberto Briganti, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.056: Metastatic Prostate Cancer and COVID-19: Do Current Data Allow Modification of Established Treatment Recommendations?
    Thomas C; Grüllich C; Erb HHH
    Eur Urol Focus; 2020 Sep; 6(5):1135-1136. PubMed ID: 32534970
    [No Abstract]   [Full Text] [Related]  

  • 39. Reply to Pim J. van Leeuwen and Henk G. van der Poel's Letter to the Editor re: Karim A. Touijer, Robert J. Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.
    Touijer K
    Eur Urol; 2018 Jul; 74(1):e18-e19. PubMed ID: 29691082
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: Christian Bolenz, Stephen J. Freedland, Brent K. Hollenbeck, et al. costs of radical prostatectomy for prostate cancer: a systematic review. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.08.059.
    Rassweiler J
    Eur Urol; 2013 Apr; 63(4):e53-6. PubMed ID: 23312570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.